Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma
Author:
Funder
National Natural Science Funds of China
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Molecular Biology
Reference65 articles.
1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN;Ferlay;Int J Cancer,2015
2. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007
3. Promotion of growth factor signaling as a critical function of beta-catenin during HCC progression;Kim;Nat Commun,2019
4. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011
5. Molecular targeted therapy for the treatment of gastric cancer;Xu;J Exp Clin Cancer Res,2016
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A genetic variant in the TAPBP gene enhances cervical cancer susceptibility by increasing m6A modification;Archives of Toxicology;2024-07-12
2. Sorafenib Resistance Contributed by IL7 and MAL2 in Hepatocellular Carcinoma Can Be Overcome by Autophagy-Inducing Stapled Peptides;Cancers;2023-11-03
3. Cancer Immunology: Immune Escape of Tumors—Expression and Regulation of HLA Class I Molecules and Its Role in Immunotherapies;Advances in Anatomic Pathology;2022-12-15
4. Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights;Frontiers in Pharmacology;2022-08-22
5. The Synergistic Cytotoxic Effects of GW5074 and Sorafenib by Impacting Mitochondrial Functions in Human Colorectal Cancer Cell Lines;Frontiers in Oncology;2022-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3